CORD-19:12fbecd4737a9af7b8fab5267094fdfa754f25fa / 4749-4948 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/12fbecd4737a9af7b8fab5267094fdfa754f25fa","sourcedb":"CORD-19","sourceid":"12fbecd4737a9af7b8fab5267094fdfa754f25fa","text":"Therefore, we have begun to separate both traditional and novel adjuvants into two main categories (immune potentiators and delivery systems) on the basis of their dominant mechanism(s) of action 2 .","tracks":[{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T26","span":{"begin":0,"end":199},"obj":"Sentence"}],"attributes":[{"subj":"T26","pred":"source","obj":"CORD-19_Custom_license_subset"}]},{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T26","span":{"begin":0,"end":199},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"TextSentencer_T26","pred":"source","obj":"CORD-19-Sentences"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19_Custom_license_subset","color":"#c293ec","default":true},{"id":"CORD-19-Sentences","color":"#93eca8"}]}]}}